FDA Approves Genentech’s Susvimo for Diabetic Retinopathy

May 26, 2025 - 22:00
 0  0
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
South San Francisco, CA -- May 22, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0